Literature DB >> 12086159

Familial occurrence of autoimmune diseases and autoantibodies in a Caucasian population of patients with systemic lupus erythematosus.

S Corporaal1, M Bijl, C G M Kallenberg.   

Abstract

To determine the prevalence of autoimmune diseases and autoantibodies in relatives of Caucasian patients with systemic lupus erythematosus (SLE) we questioned 118 patients for the prevalence of autoimmune diseases in their relatives. Multicase SLE families were selected for further investigation: assessment of the presence of antinuclear antibodies (ANA), thyroid antibodies and IgM rheumatoid factor (IgM-RF). Thirty-three patients reported the presence of 50 autoimmune diseases in 43 relatives. Twenty-two diagnoses could be either confirmed (n=14) or refuted (n=8). SLE clustered significantly within families of SLE patients. Multiple sclerosis and rheumatoid arthritis also seemed to cluster within families of lupus patients. The prevalence of ANA (24%) and thyroid antibodies (44%) in 29 relatives of multicase SLE families was raised (P<0.05). In conclusion, the prevalence of autoimmune diseases is raised in relatives of Caucasian SLE patients. Also, the prevalence of autoantibodies is raised in relatives of multicase SLE families, both suggesting genetic influences in the pathogenesis of the disease. These findings support the genome-wide screening of SLE patients to unravel factors responsible for genetic susceptibility to SLE.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12086159     DOI: 10.1007/pl00011215

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  7 in total

1.  A Link Between Plasma Microbial Translocation, Microbiome, and Autoantibody Development in First-Degree Relatives of Systemic Lupus Erythematosus Patients.

Authors:  Elizabeth Ogunrinde; Zejun Zhou; Zhenwu Luo; Alexander Alekseyenko; Quan-Zhen Li; Danielle Macedo; Diane L Kamen; Jim C Oates; Gary S Gilkeson; Wei Jiang
Journal:  Arthritis Rheumatol       Date:  2019-09-27       Impact factor: 10.995

2.  Association of STAT4 rs7574865 polymorphism with autoimmune diseases: a meta-analysis.

Authors:  Ya-Ling Liang; Hua Wu; Xi Shen; Pei-Qiang Li; Xiao-Qing Yang; Li Liang; Wei-Hua Tian; Li-Feng Zhang; Xiao-Dong Xie
Journal:  Mol Biol Rep       Date:  2012-06-20       Impact factor: 2.316

3.  Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus.

Authors:  Tamara Vyshkina; Andrew Sylvester; Saud Sadiq; Eduardo Bonilla; Jeff A Canter; Andras Perl; Bernadette Kalman
Journal:  Clin Immunol       Date:  2008-08-16       Impact factor: 3.969

4.  A comprehensive analysis of shared loci between systemic lupus erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap.

Authors:  Paula S Ramos; Lindsey A Criswell; Kathy L Moser; Mary E Comeau; Adrienne H Williams; Nicholas M Pajewski; Sharon A Chung; Robert R Graham; Raphael Zidovetzki; Jennifer A Kelly; Kenneth M Kaufman; Chaim O Jacob; Timothy J Vyse; Betty P Tsao; Robert P Kimberly; Patrick M Gaffney; Marta E Alarcón-Riquelme; John B Harley; Carl D Langefeld
Journal:  PLoS Genet       Date:  2011-12-08       Impact factor: 5.917

5.  IL2RA/CD25 gene polymorphisms: uneven association with multiple sclerosis (MS) and type 1 diabetes (T1D).

Authors:  Antonio Alcina; María Fedetz; Dorothy Ndagire; Oscar Fernández; Laura Leyva; Miguel Guerrero; María M Abad-Grau; Carmen Arnal; Concepción Delgado; Miguel Lucas; Guillermo Izquierdo; Fuencisla Matesanz
Journal:  PLoS One       Date:  2009-01-06       Impact factor: 3.240

Review 6.  How do autoimmune diseases cluster in families? A systematic review and meta-analysis.

Authors:  Jorge Cárdenas-Roldán; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  BMC Med       Date:  2013-03-18       Impact factor: 8.775

7.  Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations.

Authors:  G Kristjansdottir; J K Sandling; A Bonetti; I M Roos; L Milani; C Wang; S M Gustafsdottir; S Sigurdsson; A Lundmark; P J Tienari; K Koivisto; I Elovaara; T Pirttilä; M Reunanen; L Peltonen; J Saarela; J Hillert; T Olsson; U Landegren; A Alcina; O Fernández; L Leyva; M Guerrero; M Lucas; G Izquierdo; F Matesanz; A-C Syvänen
Journal:  J Med Genet       Date:  2008-02-19       Impact factor: 6.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.